Podcasts about dartmouth institute

Welcome to Dean's Chat Dr. Rachel Albright! Drs. Jensen and Richey are thrilled to discuss “all things podiatric medicine and surgery” with Dr. Albright. Dr. Albright is currently practicing with Stamford Health Medical Group in Connecticut. Dr. Albright holds a Master's degree in Public Health from The Dartmouth Institute, Geisel School of medicine and a Bachelors degree In Business Management with a minor in chemistry from the University of South Florida. She completed her Doctorate of Podiatric Medicine Degree from Scholl College and went on to do a 3 year surgical residency at John H. Stroger Hospital of Cook County and Advocate Illinois Masonic Medicine Center.  Join us as she discussed her passion for Research and public health including her experience in health economic models which she learned during a unique opportunity to study abroad at the University of Oxford in the field of Applied methods of cost-effectiveness analysis. We discuss the multiple organizations that she has served in leadership roles with application of her exceptional research acumen including APMA and ACFAS. She also serves as Deputy Editor with the Journal of Foot and Ankle Surgery and Associate editor for the Journal of Podiatric Medical Association as well as a reviewer for Foot and Ankle International, Gerontology and even reviews grants for international organizations.   With her passion for research, she is also an exceptional faculty member with numerous publications and invited lectures across a multitude of professional organizations. She serves as faculty for the AO North America, UT RGV and Scholl College as well as Dartmouth College teaching qualitative methods and survey research methods. Tune in, to discover what passions Dr. Albright has outside of medicine and how she recharges her batteries after giving back so much to the profession! We hope you enjoy this incredible episode!  https://www.abfas.org/residents https://www.apma.org/ https://www.acfas.org/ https://www.aofoundation.org/aona  

About Dr. Laleh Talebian:Dr. Laleh holds a bachelor's degree in Genetics and Food Biochemistry, a Ph.D. in Molecular & Cellular Biology from Dartmouth Medical School, and completed a post-doctoral fellowship on biomarkers for Cystic Fibrosis. She directed a clinical research lab on immunotherapy for blood cancers and served as a Research Project Manager at the Dartmouth Institute for Health Policy & Clinical Practice.Realizing her true calling, she became a certified health coach for patient care in 2019. Today, as a Nutritional Healing Doctor, she helps people with chronic conditions, cancer, obesity, and overweight issues heal through food prescriptions.She enjoys cycling, gardening, cooking, and reading.In this episode, Jennie Bellinger and Dr. Laleh Talebian discuss:Personal Health Journey Through FoodCustomized Nutrition Based on GeneticsRoot Cause Approach to Chronic ConditionsHealthy Plate Concept Without Complex CalculationsEpigenetics and Controllable Health OutcomesKey Takeaways:Food is a powerful tool for managing chronic conditions.Traditional diets often fail because they're not tailored to individual needs; on the other hand, listening to your body and recognizing how specific foods impact your health is crucial for long-term wellness.By making intentional choices about nutrition and lifestyle, individuals can positively influence their genetic expression.Diagnostic testing goes beyond surface-level health assessments.Simplifying nutrition can make sustainable health changes more achievable, and the "healthy plate" concept eliminates complex calculations, making it easier for people to make informed dietary choices without feeling overwhelmed."One in three people listening to this podcast is diagnosed with cancer.” — Dr. Laleh TalebianConnect with Dr. Laleh Talebian:  Facebook Name: https://www.facebook.com/profile.php?id=61554963903409Facebook Business Page: https://www.facebook.com/profile.php?id=61558516023406LinkedIn URL: https://www.linkedin.com/in/drlalehphd/Instagram Business Link: https://www.instagram.com/dynamicnaturaladvantage/Link to Gift from Dr. Laleh Talebian:Dr. Laleh's Gift for Healthy Badass Crew is her Healthy Plate One Page Guide: https://www.dynamicnaturaladvantage.com/healthy-plate  Dr. Laleh's Gift for Badass Crew who are dealing with a chronic condition is her monthly complimentary webinars called “Eat To Defeat ___________” Join her live here: https://dynamicnaturaladvantage.com  Connect with Jennie:Website: https://badassdirectsalesmastery.com/Email: jennie@badassdirectsalesmastery.comFacebook personal page: https://facebook.com/jbellingerPLFacebook podcast page: http://facebook.com/BadassDirectSalesMasteryFacebook group for Badass Crew: https://facebook.com/groups/BadassDirectSalesMomsInstagram: https://instagram.com/BadassDirectSalesMasteryPersonal Instagram: https://www.instagram.com/thedirectsalesdomme/LinkedIn: https://linkedin.com/in/BadassDirectSalesMasteryThe Badass Direct Sales Mastery Podcast is currently sponsored by the following:Bella Grace Elixir: https://shopbellagrace.com/?ref=jenniebadassdirectsalesmasteryLeadBuddy Digital Marketing: Use code BDSM when checking out at https://leadbuddy.io/pro-monthly-9310?am_id=jennie582Show Notes by Podcastologist: Hanz Jimuel AlvarezAudio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.

In episode 179 of the Thyroid Answers Podcast, I discuss thyroid cancer with Louise Davies, MD.  Topics covered in this episode include: The types of thyroid cancer. Is thyroid cancer on the rise? Thyroid nodules identified and the next steps. Why suppressing TSH with T4 medication is a strategy to prevent thyroid cancer from returning. Could inappropriate use of thyroid medication be harmful? Typical treatment strategies for thyroid cancer. And more... Louise Davies is Professor of Surgery - Otolaryngology – Head and Neck Surgery at the Geisel School of Medicine at Dartmouth, and of The Dartmouth Institute for Health Policy and Clinical Practice. Her clinical practice focus is thyroid and parathyroid disease and cancers of the head and neck.   She is best known for her work defining the problem of overdiagnosis in thyroid cancer. In recent years, she has focused on mitigating the harm that can come from overdiagnosis, working to develop evidence that can inform patient and physician decision-making. Her research has also focused on population health issues, including making recommendations for thyroid monitoring after nuclear accidents and the recovery of the healthcare system after the pandemic .

Want to transform patient care through powerful storytelling? This episode features Greg Kotzbauer, co-founder of the About Me Institute, who shares his path from healthcare tech to championing value-based care at Dartmouth Institute for Health Policy and Clinical Practice. Discover how his efforts are steering organizations away from fee-for-service models towards systems that prioritize patient well-being and high-value care.In this enlightening episode, we unpack the concept of value-based care, where outcomes take precedence over costs. Learn how proactive screenings and preventive measures, inspired by Sweden's patient-centered approach, can transform healthcare. We also spotlight initiatives in North Carolina aimed at fostering meaningful provider-patient conversations, centering care around individual goals and preferences. Dive into stories and strategies that place the patient's voice at the forefront of healthcare.Explore innovative tools that are reshaping patient-centered care, including the introduction of the About Me Care Card by Greg Kotzbauer. We delve into the success of simple yet effective methods like patient concern cards and their integration into Electronic Medical Records. Understand how this tool enhances communication, improves care quality, and boosts resident satisfaction, especially in senior care settings. Whether it's through data-driven conversations or personalized patient engagement, this episode reveals the transformative power of human-centered tools in healthcare.

In this episode, Amy Sylvis sits down with Gunnar Esiason, a prominent figure in the cystic fibrosis (CF) community. Gunnar delves into his remarkable journey, recounting his diagnosis at a young age and his family's commitment to raising awareness and funds for CF research through the Boomer Esiason Foundation. Despite facing challenges, Gunnar's passion for patient empowerment and early-stage drug development led him to pivotal roles in healthcare and advocacy.  Despite facing challenges with CF, Gunnar's resilience and determination led him to pursue higher education, ultimately earning an MBA and MPH. Throughout the conversation, Gunnar reflects on his life before and after receiving the breakthrough drug TRIKAFTA, describing what it was like taking his first dose. He shares personal insights into balancing work, family, and supporting the CF community, acknowledging the interconnectedness of these aspects in shaping his abundant life.  His story serves as an inspiration for all – showcasing the power of perseverance and advocacy in the face of adversity. More about Gunnar: Gunnar Esiason is a cystic fibrosis and rare disease patient leader, who is passionate about early-stage drug development, patient empowerment and health policy. He is the head of patient engagement at RA Capital's venture group, RA Ventures. Professionally, he developed a patient engagement platform for a medical nutrition company, built a venture philanthropy practice at the Boomer Esiason Foundation which has yielded more than $160 million raised for the fight against cystic fibrosis since he was diagnosed with the disease in 1993. He has consulted on clinical trial development, a real-world evidence population health study, and a cystic fibrosis-specific mental health and wellness screening tool. His blog has amassed nearly 1 million page views since 2015. His podcast, the State of Health, is available on all streaming platforms. Gunnar holds an M.B.A. from the Tuck School of Business at Dartmouth, where he was a Wilson Scholar and received the Julia Stell Award, an M.P.H. from the Dartmouth Institute for Health Policy & Clinical Practice, and a B.A. from Boston College. His health policy opinions have been featured in the Wall Street Journal, USA Today, The Hill, and STAT News. Connect with Gunner: esiason.org twitter.com/g17esiason Connect with Amy Sylvis: sylviscapital.com sylviscapital.com/webinar  linkedin.com/in/amysylvis

Jeff Wells, MD, CEO & Co-Founder, Marathon HealthJeff Wells, MD, is the CEO and co-founder of Marathon, a modern health company that partners with employers, benefit consultants and unions to deliver a health care experience that focuses on driving real behavior change, resulting in better employee health and financial savings. Marathon Health's model consists of onsite health centers, Network health centers and virtual advanced primary care. Wells, who earned his MD in internal medicine from Indiana University, was president and co-founder of OurHealth, which merged with Marathon Health in January 2020. He is the former director of Indiana's Office of Medicaid Policy and Planning.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

In this episode, we talk with Dr. Glyn Elwyn and Danielle Schubbe about the ethical imperative of including patients in the decision-making process. They discuss how patient goals inform treatment decisions and the challenge of making choices for a “future self” with the lived experiences and preferences of today. Glyn and Danielle talk about this process for early stage breast cancer and some of the tools they've created to help both clinicians and patients navigate shared decision-making, including the three-talk model. Key Highlights: The art of combining clinical guidelines and patient preference to make the best treatment decision. The role of patient goals in making decisions and realizing that decisions are being made for a “future self” using “current self” experiences. Exploring the three-talk model of decision making: team talk, option talk and decision talk. About our guests: Glyn Elwyn BA MD MSc PhD FRCGP is a clinician, researcher, and innovator. He is a tenured professor at The Dartmouth Institute for Health Policy and Clinical Practice, USA, and at the Scientific Institute for Quality of Healthcare, Radboud University Nijmegen Medical Center, Netherlands. He has Visiting Professor positions at University College London, UK, and at the University of Lausanne in Switzerland. After reading the humanities he qualified in medicine, completed a Masters in Education, and obtained his doctorate at Radboud University, Nijmegen, Netherlands, with Professor Richard Grol. Glyn Elwyn studies coproduction, shared decision making, and the application of machine learning to digital recordings of clinical encounters. Danielle Schubbe joined the Coproduction Laboratory in September 2017. She is an external PhD student of Health Services Research at Radboudumc in Nijmegen, Netherlands. She has worked on multiple PCORI-funded studies about shared decision making and the implementation of shared decision making in diverse clinical contexts. Key Moments: 19 minutes: On integrating patient preference with clinical guidelines. “I think most discerning clinicians understand how to work within guidelines, and I think most expert clinicians would say I bring in patient preference as well as know what the rules are saying or what the guidelines are saying.” 31 minutes: On the challenge of making a decision for your future self. “Your decision today about that future is gonna be misinformed because you've never experienced that future yourself.... We cannot predict you in three years' time. How will you feel? We can only ask you to do your best to predict how you feel in the future… and you will be wrong.” 49 minutes: Using the three-talk method of decision making. “Then there's the option talk. That's when you present if there is more than one option for the patient to consider for their treatment. That's when you go over all the nitty gritty of the pros and cons of the two surgical treatment options, in our case for early stage breast cancer,  in a way that is hopefully not really overwhelming for the patient.” This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features these PCORI studies by Dr. Glyn Elwyn & Danielle Schubbe - Study 1 and Study 2. Visit the Manta Cares website  Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support

Steven Woloshin is a professor of medicine and the director of the Center for Medicine and the Media at the Dartmouth Institute and a member of the Dartmouth Cancer Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Woloshin and Others. The New USPSTF Mammography Recommendations — A Dissenting View. N Engl J Med 2023;389:1061-1064.

Holding more than 20 years of experience in healthcare leadership, Laurie Lee Smith is the founder of Laurie Lee Leadership and former system CNO of Billings Clinic. Her expertise lies in supporting healthcare professionals to overcome challenges, shift mindsets, uncover blind spots, and sustain progress by incorporating the neuroscience of human behaviors. She has developed the Elevating Healthcare Leadership Impact program and the STAR methodology, both of which have proven to be instrumental in transforming teams and driving tangible results. Laurie holds a BSN from the University of Alaska aAnchorage, a masters of science in nursing administration from the University of Mary, and executive coaching certifications from the Hudson Institute of Coaching and the International Coaching Federation. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Ruth Krystopolski is President of Ayin Health Solutions at Providence Health Systems. In her role as President, Ruth leads the development of population health capabilities across Providence's ministries and extends them externally to reach additional communities.Ruth joined Ayin in November 2021 after serving as the Senior Vice President of Population Health at Atrium Health, where she was responsible for the development and implementation of value-based care models across the organization. Ruth also led the system-level Care Management, Employer Solutions and other Value-Based Programs and provided oversight of the Poison Control Center in Charlotte, NC.Ruth holds an undergraduate degree in Health Policy and Administration from Pennsylvania State University and a Master of Business Administration in Finance from the University of Pittsburgh.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Dr. John Neil is the Executive Vice President and Chief Physician Executive and Network Strategy Officer for HonorHealth in Scottsdale, Arizona. Dr. Neil drives physician engagement throughout HonorHealth, working to ensure that physicians have input and involvement in the decision-making processes of the healthcare system. His work with clinical teams focuses on strategic initiatives, operations, clinical services and the continuum of patient care.An interventional radiologist by clinical training, he joined HonorHealth as the organization's senior physician leader in 2015 and has since held leadership roles with the organization's medical staff, Scottsdale Health Partners, and the HonorHealth Board of Directors. His professional experience includes serving as the chairman of Southwest Medical Imaging, a large radiology practice that has been active in ambulatory development, practice mergers and joint ventures.Dr. Neil holds a bachelor's degree in biochemistry from the University of Kansas and graduated with honors from Washington University School of Medicine. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Chanda Chacón is the president and CEO of Children's Hospital and Medical Center in Omaha, Nebraska. Chacón came to Children's from Arkansas Children's, where she served as Executive Vice President and System Chief Operating Officer. In Arkansas, she oversaw the system operations of two hospital campuses, clinical services, human resources and support services. Prior to leading in Arkansas, she served as the President for Texas Children's Hospital West Campus, Houston's first community hospital designed exclusively for children. Chacón spent 14 years at Texas Children's Hospital—one of the nation's top pediatric health care institutions—serving in progressive leadership roles, including ambulatory operations, Heart Center, Fetal Center, Women's Services and Pharmacy.Chacón earned undergraduate degrees in Biology and Spanish from Vanderbilt University and a Master's Degree in Public Health Management from Yale University. She is a Fellow of the American College of HealthCare Executives. She has also volunteered as a court-appointed Child Advocate serving children in custody. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Alice Kennedy. Research Project Manager at The Dartmouth Institute for Health Policy and Clinical Practice USA and PHD candidate at Jönköping Academy Sweden and Nicoline Vackerberg, Development leader Region Jönköping County, Sweden explore co-production in practice and talk about how coaches might think about the drivers of co-production to brainstorm small changes they can make to increase the level of co-production in all activities.

Eugene Nelson is a professor of community and family medicine at The Geisel School of Medicine at Dartmouth and The Dartmouth Institute for Health Policy and Clinical Practice. He serves as the director of Population Health and Measurement at The Dartmouth Institute and leads a program on new models to advance the coproduction of health care. Nelson is a national leader in health care improvement and the development and application of measures of quality, system performance, health outcomes, value, and patient perceptions. His current work is focused on using patient-centered registries to develop learning health systems capable of coproducing improved health care and innovative science. He leads a Dartmouth team that is conducting national proof of concept demonstration programs for several chronic disease populations including cystic fibrosis, inflammatory bowel disease (IBD), and rheumatology.  In the early 1990's, Nelson and his colleagues at Dartmouth began developing clinical microsystem thinking. His work developing the “clinical value compass” and “whole system measures” to assess health care system performance has made him a well-recognized quality and value measurement expert.He is the recipient of The Joint Commission's Ernest A. Codman award for his work on outcomes measurement in health care. Nelson has been a pioneer in bringing modern quality improvement thinking into the mainstream of health care; he helped launch the Institute for Healthcare Improvement and served as a founding board member. He has authored over 150 publications and is an author of two recent books: Quality by Design: A Clinical Microsystems Approach and Value by Design: Developing Clinical Microsystems to Achieve Organizational Excellence.  He received an AB from Dartmouth College, an MPH from Yale University, and a DSc from Harvard University..Glyn Elwyn, is the director of the Institute's Patient Engagement program. He has assembled an international interdisciplinary team, The Preference Laboratory, examining the implementation of shared decision making into clinical settings, using innovative tools and measures, such as CollaboRATE, a patient experience measure of shared decision making and Observer OPTION, for use on recorded data. Members of the team have led the development of Option Grids™ patient decision aids, tools designed to support collaboration between clinicians and patients.He holds chair appointments at the Scientific Institute for Quality of Healthcare, University Nijmegen Medical Centre, Netherlands, the Cochrane Institute for Primary Care and Public Health, Cardiff University, and at University College London. He is the lead editor of Shared decision making: Evidence Based Patient Choice, Oxford University Press, 3rd edition, 2016. Learn more about The Dartmouth Institute Coproduction Laboratory

This week on Faisel & Friends, we are discussing Shared Decision Making - Ways to Engage and Interact with Patients. We are talking with Professor Glyn Elwyn from The Dartmouth Institute for Health Policy. Our conversation explores how important it is for physicians to stay curious about each patient's individual circumstances, combating burnout through the intrinsic rewards of a meaningful doctor-patient relationship, and the promising future of electronic medical records via the help of artificial intelligence from a new company called Abridge.To learn more about Professor Elwyn's work with abridge, visit: https://www.abridge.comBeing a doctor is your calling because you couldn't imagine doing anything else. Let's talk about your career goals in medicine. Connect with us and tell us how you dream of practicing medicine. Want to learn more about how we do healthcare? Visit our resource center and check out how we are transforming healthcare. Don't forget to subscribe to ChenMed Rx to receive the latest news and articles from ChenMed.

Gunnar Esiason is a cystic fibrosis and rare disease patient leader, who is passionate about early-stage drug development, patient empowerment and health policy. Professionally, he developed a patient engagement platform for a medical nutrition company, built a venture philanthropy practice at the Boomer Esiason Foundation and was the head coach of his high school alma mater's varsity hockey team. He has consulted on clinical trial development, a real-world evidence population health study, and a cystic fibrosis-specific mental health and wellness screening tool. Gunnar has been the face of fundraising efforts for the Boomer Esiason Foundation, which has yielded more than $160 million for the fight against cystic fibrosis since he was diagnosed with the condition in 1993. Gunnar holds an M.B.A. from the Tuck School of Business at Dartmouth, an M.P.H. from the Dartmouth Institute for Health Policy & Clinical Practice, and a B.A. from Boston College. He sits on the board of directors at the Boomer Esiason Foundation and No Patient Left Behind. His health policy opinions have been featured in the Wall Street Journal, USA Today, The Hill, and STAT News. He currently leads patient-facing strategy at Florence Healthcare. This week we discuss Gunnar's experience as a clinical trial participant, decentralized clinical trials, participant reimbursement and so much more.

In this episode, we talk to Dr Satveer Kaur-Gill, a postdoctoral Research Associate at The Dartmouth Institute for Health Policy & Clinical Practice, as she shares about the challenges the marginalised face in navigating health infrastructure. We discuss about cultural and structural competence when assessing any patient, especially the underprivileged, and most importantly how to make research impactful for target communities.

This episode was made in partnership with the Newborn Medicine subcommitee of the American Academy of Pediatrics - Section on Hospital Medicine.    Course: Hyperbilirubinemia in the newborn 35 weeks or more – Updated Guidelines!  Course Director: Tony R Tarchichi MD  - Associate Professor in Dept of Pediatrics at the University of Pittsburgh School of Medicine Course Director: Alison Volpe Holmes, MD, MS, MPH. - Associate Professor of Pediatrics and of the Dartmouth Institute, Geisel School of Medicine at Dartmouth  This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.  This episode is Hyperbilirubinemia in the newborn 35 weeks or more – Updated Guidelines! As always there is free CME credit of up to 1.25 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.  ______________________________________________________ Objectives: Upon completion of this activity, participants will be able to: Review the treatment of hyperbilirubinemia in the newborn 35 weeks or more. Review the definition of Kernicterus. Review the management and when to escalate care in infants more than 35 weeks old who have hyperbilirubinemia. ______________________________________________________ Released:  12/18/2022, Reviewed 12/18/2022, Expire: 12/18/2023 If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account: Step 1. Create an Account https://www.hsconnect.pitt.edu/HSC/home/create-account.do If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training: Step 2. To access the test for CME credit: https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=23974&dev=true Accreditation Statement: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material for a maximum of  (1.25)  AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Heitham Hassoun, MD, Vice President & Medical Director, Cedars-Sinai InternationalDr. Heitham Hassoun is the Vice President & Medical Director for Cedars-Sinai International in Los Angeles, California. He previously served as Global Medical Director for Johns Hopkins Medicine and was an Associate Professor in the Department of Surgery at The Johns Hopkins University School of Medicine.Dr. Hassoun has a wealth of experience in international patient services, global collaborations and health system development. He was instrumental in the creation of Johns Hopkins Aramco Healthcare, a joint venture between Saudi Aramco and Johns Hopkins Medicine, as well as a number of other institutional management and affiliation agreements throughout the Middle East and Asia. Currently, he aims to expand the global footprint of Cedars-Sinai.Dr. Hassoun maintains a clinical practice in vascular & endovascular surgery and he continues to educate and research in a variety of topics related to global collaborative healthcare and academic medicine. He completed his fellowship training in vascular and endovascular surgery at Northwestern University in Chicago and earned his medical degree at Baylor College of Medicine in Houston.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

We're discussing Leaving the Healthcare System Better than We Found It on this episode of Faisel & Friends! Faisel and Dan are joined by Dr. Elliott Fisher, Professor of Medicine and Health Policy at The Dartmouth Institute and Senior Fellow at the Institute for Healthcare Improvement. Our conversation revolves around how to make the American healthcare system better for patients, physicians, and the public and the fun Dr. Fisher has had getting involved with advocacy and policy change.Being a doctor is your calling because you couldn't imagine doing anything else. Let's talk about your career goals in medicine. Connect with us and tell us how you dream of practicing medicine. Want to learn more about how we do healthcare? Visit our resource center and check out how we are transforming healthcare. Don't forget to subscribe to ChenMed Rx to receive the latest news and articles from ChenMed.

Rob Allen, FACHE, President and Chief Executive Officer, Intermountain HealthcareRob Allen, FACHE, was named as the new president and chief executive officer of Intermountain Healthcare and began serving in that role on December 1, 2022. Previously, Rob served as the organization's senior vice president and chief operating officer. In addition to Rob's 25-plus years of executive leadership at Intermountain, he has also held CEO roles at hospitals and health systems in Wyoming, New Jersey, and Massachusetts.A fellow of the American College of Healthcare Executives, Rob has served on many foundation, chamber, and service boards. Rob earned a Master of Business Administration degree from Utah State University and a Bachelor of Science degree in operations management from Brigham Young University. His passion for healthcare began during his childhood as he was raised on a farm in Star Valley, Wyoming, where his mother served as a nurse and later as administrator at Star Valley Hospital. He and his wife, Becky, have three children and four grandchildren.Intermountain Healthcare is headquartered in Utah with locations in eight states and additional operations across the western U.S. Intermountain is a nonprofit system of 33 hospitals, 385 clinics, 60,000 employees, medical groups with some 3,900 employed physicians and advanced care providers, a health plans division called SelectHealth with more than one million members, and other health services. With its mission of “Helping people live the healthiest lives possible,” Intermountain is committed to improving community health and is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes at sustainable costs.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Dr. Robert Jarve is the Associate Chief Medical Officer for Population Health at Corewell Health West. In this role, he leads the strategy and development of population health analytics capabilities for the system, as well as the implementation of a value-based care model for underserved, high-risk patients. He is also leading a pilot to help house at-risk patients who are experiencing homelessness.In addition to his administrative responsibilities, Dr. Jarve practices as an internal medicine and pediatrics physician, providing primary care to high-risk patients one day a week. He has diverse experience in population health management, including implementing and leading care management teams, developing care pathways and analytics solutions, and leading the change management of health care teams to more integrated team care models. Dr. Jarve holds BS and MSc degrees from Michigan State University, an MD degree from Wayne State University, and an MBA from Grand Valley State University.Dr. Jarve has lived in Michigan his whole life and enjoys spending time with his wife, two teenage boys, and pets. Outside work, his favorite activities are hiking, reading, traveling, and snowboarding. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

There's ongoing debate as to whether some preventative screenings are helpful in the general population because of risk associated with doing procedures and unnecessary treatment leading to higher healthcare costs. A recent study from Poland, Norway, and Sweden showing a relatively similar risk of death from colorectal cancer between screened and unscreened populations highlights this dilemma. We are joined by Dr. Audrey Calderwood, a gastroenterologist at Dartmouth in Lebanon. She is the director of the Comprehensive Gastroenterology Center and Associate Professor of Medicine at Geisel School of Medicine at Dartmouth and the Dartmouth Institute for Health and Policy and Clinical Practice. Her passions from both a clinical and research perspective is colorectal cancer prevention. She will walk us through some of the higlights of the study which we hope will help our listeners make an informed decision. The information shared in this episode is meant for medical education and should not be considered as medical advice.

In his role as Strive Health's Vice President of Strategy & Development, Jackson Brasher draws on more than 15 years of experience to lead Strive Health's system team in their company mission to transform kidney care.Before joining the leadership team at Strive, Jackson held corporate strategy and business development roles at The Advisory Board Company, Trilliant Health, and Cardinal Health –  working with hospitals, health systems, and provider practices across the country on various innovation and growth initiatives. Jackson holds a B.A. from the University of Virginia and an M.B.A. from Duke. A Nashville native, Jackson enjoys spending time with his wife, daughter and the family's playful black lab. Outside of the office, he can be found on the lake, at a concert, or planning his next big trip. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

David Stewart, MD; Head, Division of Medical Oncology, University of Ottawa; Author, A Short Primer on Why Cancer Still SucksDr. Stewart received his MD degree from Queen's University, Kingston, followed by training in internal medicine at McGill University and in medical oncology in the Department of Developmental Therapeutics at the UT MD Anderson Cancer Center. He first moved from MD Anderson to the University of Ottawa in 1980, and served as Chief of Medical Oncology at the Ottawa Civic Hospital from 1989 to 1999. He returned to the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center from 2003 to 2011 where he served as Chief of the Section of Experimental Therapeutics (2003-2005), Chair Ad Interim (2005), Deputy Chair (2006-2009), and Director of Translational Research (2009-2011). He was also the Principle Investigator of MD Anderson' phase II N01 contract with the National Cancer Institute, and was the clinical leader of a number of other federally-funded translational research projects. In 2011, Dr. Stewart returned to Ottawa from the University of Texas MD Anderson Cancer Center (Houston, TX) in 2011 to assume the position of Head of the Division of Medical Oncology at The Ottawa Hospital and the University of Ottawa. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Adam Wilson founded BioPharmGuy in 2008 after gaining engineering and government experience in biotech. Professional stops prior to BioPharmGuy include Biopure (Cambridge, MA), FDA (Detroit, MI) & Henry Ford Hospital (Detroit, MI). His formal educational background consists of a Chemical Engineering Bachelors ('02) and Pharmaceutical Engineering Masters ('06) both from the University of Michigan. BioPharmGuy currently operates out of West Lafayette, IN. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Chris is the Chief Executive Officer (CEO) of Landmark Health. Chris joined Landmark in 2017 as Vice President and General Manager responsible for launching the New England market. Most recently, Chris has served as Landmark's Head of Corporate Development responsible for the company's growth strategy, strategic partnerships, mergers and acquisitions, and public policy. In this position, Chris played an integral role in spearheading Landmark's merger with Optum and leading the company's integration into Optum's Home and Community platform.Prior to Landmark, Chris was a Principal at Innosight, a healthcare focused growth strategy consultancy and Co-founder of Predilytics, a healthcare analytics business. Chris holds a Bachelor of Arts in economics from Harvard College. He also received his M.B.A. from Harvard Business School. Chris resides in Newton, Massachusetts with his wife and three young children. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

S1E43: On this episode, Variation and Waste in Healthcare with Elliott Fisher, MD from the Dartmouth Institute for Health Policy and host Dr. Nick. Have you seen headlines that your Zip code is more important than your genetic code in determining your health and life expectancy? This is a window into the care being delivered and the fundamental inequities and health disparities that are pervasive and amplified by the pandemic. A New Yorker article “The Cost Conundrum” focused on McAllen, Texas which is one of the most expensive districts for healthcare expenditure in the US. Did this work demonstrate this additional spending results in better outcomes for the patients receiving healthcare? Based on the standard metrics of quality of care it does not. Your better pill to swallow is to acknowledge that each intervention and treatment comes with its own set of risks and rewards. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

John Gorman is the founder and Chairman of Nightingale Partners, the first Opportunity Zone fund to invest in social determinants of health interventions with health insurers, states, and provider organizations. He also founded and is the former Executive Chairman of Gorman Health Group. John's work focuses on Medicare, Medicaid, and Affordable Care Act strategy, governance, and turnaround of distressed health plans. Prior to founding his firm, John served as Assistant to the Director of Health Care Financing Administration's (HCFA, now CMS) Office of Managed Care, where he provided day-to-day management and served as the external liaison for the Medicare and Medicaid managed care programs.John's career in Washington began as Press Secretary and Staff Director for U.S. Representative John Conyers, Jr. (D-MI), then Chairman of the Government Operations Committee. John serves on the Board of Directors of Henry Ford Health System's Health Alliance Plan in his birthplace of Detroit, MI, and serves as a Senior Advisor to Premier, Inc., the hospital purchasing cooperative, on Medicare Advantage and Medicaid matters. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Meet Amber Barnato, M.D.:Amber Barnato, M.D. is the John E. Wennberg Distinguished Professor and the Director of The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth. She is trained in two medical specialties, public health and preventive medicine, and hospice and palliative medicine. Dr. Barnato received a bachelor's from the University of California at Berkeley, an M.D. from Harvard Medical School, an MPH from the University of California at Berkeley, and an MS from Stanford University. Key Insights:Amber Barnato, M.D. explores how her medical career experiences led her to the focus of palliative and end-of-life care.  Expanding Horizons. Dr. Barnato took a year before medical school to be a research assistant and speech writer for Assistant Surgeon General Dr. McGinnis. That experience expanded her horizons, exposing her to the policy process, and Dr. McGinnis served a sponsor, improving her medical school candidacy.Path to Palliative Care. Dr. Barnato was morally distressed by the end-of-life care she saw in her general surgery internship, which lacked emotional support, conversations with family, and concerns over quality of life. After listening to a story about end-of-life care research on the radio, she decided she wanted to join the research effort herself. Next Steps for the Dartmouth Atlas. The Dartmouth Atlas focuses on overuse and unwarranted variation of healthcare. However, Dr. Barnato wants the Atlas to expand to underuse and unjust variation. She would like to see a focus on health equity.  This episode is hosted by Joanne Conroy, M.D. She is a member of the Advisory Council for Her Story and is the CEO and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health. Relevant Links:Learn more about Dr. Barnato and her researchFollow Dr. Barnato on Twitter

A.J. LoiaconoAJ is a successful entrepreneur, with 20 years of experience in pharmacy benefits and software development. As the CEO of Capital Rx, his mission is to change the way pharmacy benefits are priced and administrated in the US. Prior to Capital Rx, AJ was a co-founder of Truveris, where he served for eight years as CEO, Chief Innovation Officer, and Board Member, leading the company to record growth (Deloitte FAST 500 and Crain's Fast50).  Prior to Truveris, AJ co-founded SMS Partners, a joint venture with Realogy (RLGY), and in 2010 exited the partnership with a buyout. In his first venture, AJ started Victrix, a pharmaceutical supply chain software consultancy, and successfully sold the company to Chrysalis Solutions in 2007. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Dr. Robert PearlNamed one of Modern Healthcare's 50 most influential physician leaders, Dr. Pearl is an advocate for the power of integrated, prepaid, technologically advanced and physician-led healthcare delivery.He serves as a clinical professor of plastic surgery at Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business, where he teaches courses on strategy and leadership, and lectures on information technology and health care policy.Dr. Pearl is the author of “Mistreated: Why We think We're Getting Good Healthcare—And Why We're Usually Wrong,” a Washington Post bestseller that offers a roadmap for transforming American healthcare. He hosts the popular podcast Fixing Healthcare, publishes a newsletter with over 10,000 subscribers called Monthly Musings on American Healthcare and is a regular contributor to Forbes.  He has published more than 100 articles in medical journals and contributed to numerous books.Board certified in plastic and reconstructive surgery, Pearl received his medical degree from the Yale University School of Medicine, followed by a residency in plastic and reconstructive surgery at Stanford University. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Jason Gorevic is chief executive officer and a member of Teladoc Health's board of directors. Since taking the reins in 2009, he has led Teladoc Health to its position today as the world leader in virtual care, achieving significant growth in revenue, membership, and telehealth utilization. Under his leadership the company has established a proven track record of successfully shaping the market and driving healthcare transformation by executing on the strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition. Nationally recognized as a thought leader and trailblazer in the virtual delivery of healthcare, Mr. Gorevic is fueled by a passion for improving healthcare outcomes and providing universal access to care. His extensive career in healthcare began at Oxford Health, and he has also held executive leadership roles at WellPoint, Inc. (now Anthem, Inc.) and Empire BlueCross BlueShield.He holds a Bachelor of Arts in International Relations from the University of Pennsylvania. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University. John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Parenting a child with intellectual disability can feel overwhelming at times. But it can also be wonderfully rewarding. Leading IDD expert Dr. Ambrose answers the most commonly asked questions about intellectual disabilities searched online in this episode of You Ask, We Answer. – Adrian Jacques H Ambrose, MD, MPH, FAPA Dr Ambrose is currently the Medical Director of the Psychiatry Faculty Practice Organization at Columbia University. Integrating business development with clinical medicine, he also previously served as a subspecialist consultant in operations management and design thinking for industry through the Mass General Brigham Connected Health. For almost a decade, Dr Ambrose has also served as private consultant in user engagement, market entry, diversity/equity/inclusion (DEI) program development, wellness promotion, and burnout prevention for Mid-to-Large Size Companies, and executives and management leaders. Clinically, Dr Ambrose specializes on treatment resistant mood disorders for both the adult and child & adolescent populations. In interventional neurotherapeutic psychiatry, Dr Ambrose also provides procedures in esketamine, ketamine, electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). Dr Ambrose completed his medical trainings at Dartmouth and MGH, public health training at the National Center for Primary Center, and value-based healthcare training at the Dartmouth Institute for Health Policy & Clinical Practice. He completed the Commonwealth Minority Health Policy Fellowship at Harvard Medical School and has a Master's in Healthcare Management and Public Policy from Harvard University. – If you enjoy this podcast, be sure to follow or subscribe wherever you are listening, and share You Ask, We Answer with your colleagues and friends. You can also listen to the podcast version here: https://anchor.fm/you-ask-we-answer You Ask, We Answer is a co-production from Psych Hub and Columbia University Department of Psychiatry, and brought to you by HCA Healthcare. This show is for educational purposes only. Visit https://psychhub.com to dig deeper and access the world's most comprehensive platform for behavioral health education. Follow us on Social Media Twitter: https://twitter.com/PsychHub Instagram: https://www.instagram.com/psychhubeducation YouTube: https://www.youtube.com/c/PsychHub

Tzvia Bader, CEO and Co-Founder of TrialJectory is a savvy and experienced entrepreneur, with decades of experience in business development, product marketing, and strategy. Prior to co-founding TrialJectory, Tzvia headed the global business unit at Amdocs where she was responsible for building a new product growth strategy, as well as for global sales and marketing. Tzvia has held different business development and marketing positions in several tech companies, both B2B and B2C. She holds a Master of Science  degree from the University of Nottingham, in Nottingham, UK. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Season 2 | Episode 21 | May 25, 2022Amber E. Barnato, MD, MPH, MS, director of the Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth, is the next guest on Medical Matters Weekly  on Wednesday, May 25. The show will cover Barnato's wide range of expertise, including public health/preventive medicine, hospice/palliative medicine, the institute's work, health equity, and Barnato's research regarding life support decisions families and physicians make for patients in the ICU.In addition to her role as director of the Dartmouth Institute, Barnato is the John E. Wennberg Distinguished Professor at the Geisel School of Medicine at Dartmouth. The Institute is both an academic department and a cross-campus institute bringing together more than 150 faculty who serve the mission of improving health and health care by conducting research jointly with staff and academic, health system, and community partners and by teaching and learning from more than 200 graduate students annually in the department's MS, MPH, MHCDS, and PhD programs.Barnato is trained in two medical specialties, public health/preventive medicine and hospice/palliative medicine.  Her own research focuses on understanding the causes and consequences of variation in end-of-life intensive care unit (ICU) and life-sustaining treatment use among seriously ill older adults. She focuses on the interplay between organizational norms, provider-patient communication, and implicit cognition, and how these phenomena produce racial disparities in end-of-life treatment.Medical Matters Weekly features the innovative personalities who drive positive change within health care and related professions. The show addresses all aspects of creating and maintaining a healthy lifestyle for all, including food and nutrition, housing, diversity and inclusion, groundbreaking medical care, exercise, mental health, the environment, research, and government. The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. The show is also available to view or download a podcast on www.svhealthcare.org/medicalmatters.Underwriter: Mack Molding

Alice Benjamin, MSN, APRN, ACNS-BC, FNP-C, CCRN, CEN, CV-BC, also known as 'Nurse Alice', is a cardiac clinical nurse specialist and family nurse practitioner with over 23 years of healthcare experience. Alice is Nurse.org's Chief Nursing Officer and Correspondent and is a regular contributor to NBC Los Angeles. She hosts the popular 'Ask Nurse Alice' podcast that reached #9 in the Apple Podcasts medical category. Nurse Alice is passionate about empowering nurses to use their voices on a grander scale. She has spoken on the subject of Nurses Using Media as a Form of Advocacy at several nursing schools and organizations including UCLA, Howard University, and UC Davis.  John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the Graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Michelle Troseth and Tracy Christopherson are co-founders of MissingLogic®. They help healthcare organizations and healthcare leaders combat burnout through the power of a framework driven approach founded on Polarity Intelligence™. The core of their work is leading healthcare organizations through transformational change that results in the best place to give and receive care, and for leaders to live their best lives both personally and professionally.Michelle and Tracy have been interprofessional leaders, friends and colleagues for over 30 years. They are co-hosts of a top healthcare leadership podcast, Healthcare's MissingLogic. Michelle and Tracy have a combined experience of more than 60 years working as consultants and coaches for healthcare organizations across North America supporting healthcare leaders as they strive to create healthy, healing work cultures. They frequently speak at national and international leadership conferences on the topics of managing healthcare polarities, achieving work life balance and living a resilient life.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

Linda Hand brings 35 years of experience to her role as CEO of Prealize Health, with an emphasis in organizational leadership, product development, solutions delivery and go-to-market strategies across a diverse portfolio of industries. Before joining Prealize, Linda led the Clinical Trial Optimization Solutions division at IQVIA, where she was responsible for creating and delivering a suite of innovative clinical technology products, fueled by predictive analytics and machine learning algorithms, to drug development organizations worldwide.Linda is a past President and CEO of the San Francisco-based DecisionView, the leading provider of clinical trial enrollment optimization solutions. She also ran product development and delivery at a number of leading software companies, including DigitalThink, Hyperion, Arbor Software and Sybase.Linda holds a BA in Computer Science from the University of California, Berkeley, and completed the Haas School of Business Executive Program.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Summer Knight, MD, MBA, a former firefighter/paramedic-turned primary care and emergency room doctor, is a Managing Director in Deloitte Consulting's Life Sciences & Health Care practice.  She is a passionate advocate for humanizing healthcare, an innovative leader in digital and virtual health, and a pragmatic futurist who helps clients act upon today's rapid changes in healthcare.Dr. Knight maintains an active physician license, is board certified in family medicine and was Chief of Staff of a 4-hospital healthcare system and Emergency and Urgent Care Department Chair. She is an accomplished leader having held key executive positions in F100 Plan, Digital Health, Provider, Government and Private Equity.  She also has academic credentials having been an adjunct Professor and Executive-in-Residence for Healthcare at the Fox School of Business at Temple University. Her perspective on healthcare is informed not only by her professional experience, but also by her role as a patient and sandwich generation caregiver. John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

Robin Shah is the Founder and CEO of Thyme Care, an oncology care management solution providing high-touch, tech-enabled cancer care navigation. Thyme Care was founded with the mission to radically improve the journey for every person diagnosed with cancer.  At the heart of it all is the belief that providing patients with access to the right team at the right time will lead to better quality, outcomes, costs, and ultimately patient experience. Before launching Thyme Care, Robin was a founding member of OneOncology, where he served as the Chief Development and Marketing Officer. Robin's passion for building a stronger future for community oncology then brought him to Flatiron Health, a leading healthcare technology company. There, Robin served as Vice President of Provider Marketing and Strategy. Robin also helped manage a comprehensive community cancer center in his hometown, Gettysburg, PA. Robin earned his bachelor's degree in biomedical engineering from George Washington University and holds an M.B.A from the Carey Business School at Johns Hopkins University.John Marchica, CEO, Darwin Research GroupJohn Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin's client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

On the 26th of June 2015, the US Supreme Court legalised same-sex marriage across the USA, allowing same-sex couples to be legally recognised as married in all 50 states. In a study conducted one year later, Dr Kristina B. Wolff at The Dartmouth Institute for Health Policy & Clinical Practice, explored some of the benefits and costs of this legalisation for LGBTQ+ communities living in the USA. She introduced a new framework, based on the work of economist Dr Amartya Sen and philosopher Dr Martha Nussbaum, that could encourage long-lasting positive social change.

Margie is Research Professor in the Department of Nursing and Executive Director and Founder of the Institute for Excellence in Health and Social Systems (IEHSS), in the College of Health and Human Services at the University of New Hampshire. She is a national and international leader of designing and implementing improvement strategies targeting the place where patients, families and care teams meet-the clinical microsystem. Dr. Godfrey began her work in clinical microsystems over 25 years ago and, in 2009, founded The Dartmouth Institute Microsystem Academy (TDIMA) at The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine with Dartmouth colleagues, to develop new knowledge and disseminate findings. She was Co-Director of TDIMA with Dr. Tina Foster for 11 years and a Lecturer for nearly 20 years at The Dartmouth Institute for Health Policy and Clinical Practice.   Margie's primary interest is engaging inter-professional health care professionals in learning about and improving local health care delivery systems with a focus on patients, professionals, processes and outcomes. Margie is co-author of the best selling textbooks, Quality by Design (2007), Quality by Design, 2nd Edition (in press) and Value By Design (2011), and the lead author and architect of the "Clinical Microsystems: A Path to Healthcare Excellence" series. Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3 (https://www.surveymonkey.com/r/3DXCFW3) CME credit is available for up to 3 years after the stated release date Contact CEOD@bmhcc.org if you have any questions about claiming credit.

Service Leadership and Emotional Intelligence are quickly becoming the foundations of success in business.  Kris McCrea helps companies transform by aligning leadership models with nature. Are your employees counting the minutes each day? There is a better way; leading with vision and purpose, allowing people to grow to their full potential Who better to develop your customers and care for your patients than people who feel alive and vibrant. Kris McCrea, President of McCrea Coaching, is a Professional Certified Coach through the International Coaching Federation, a Master Practitioner in Energy Leadership, a Microsystems Coach through The Dartmouth Institute. She is also is an active member of the Forbes Coaches Council, so be on the lookout for her articles and comments on Forbes.com.  Learn more at https://www.mccreacoaching.com 

In December 2017, the NEJM's national corespondent, Lisa Rosenbaum, published an article “The Less-Is-More Crusade — Are We Overmedicalizing or Oversimplifying?” The article aimed a broadside against those who are campaigning against the overuse of medicine, and the over diagnosis of treatment. This week in the BMJ we've published a rebuttal to that article, and in this podcast we talk to Steve Woloshin and Lisa Schwartz - both professors at the Dartmouth Institute for Health Policy and Clinical Practice. Steve and Lisa's article carefully deconstructs some of the ideas advanced by Rosenbaum, but in this podcast we discuss how much separate camps are forming in this debate - and how to have a constructive dialogue across that divide. Read Steve and Lisa's essay https://www.bmj.com/content/361/bmj.k2035 Iona Heath's essay - The role of fear in overdiagnosis https://www.bmj.com/content/349/bmj.g6123 Stacy Carter's interview about moral shocks https://soundcloud.com/bmjpodcasts/preventing-overdiagnosis-2017-stacy-carter-on-the-culture-of-overmedicalisation

The Three Talk Model of shared decision is a framework to help clinicians to think about how to structure their consultation to ensure that shared decision making can most usefully take place. The model is based around 3 concepts - option talk, decision talk, and team talk - with active listening at the centre. Three Talk was first proposed in 2012, now new research published on bmj.com updates that model. Professor Glynn Elwyn, from The Dartmouth Institute for Health Policy and Clinical Practice, joins us to explain how that was done, and what it's creators learned from the process. Read the full research: http://www.bmj.com/content/359/bmj.j4891

This week, a new series starts in The BMJ - the aim is to rethink how hospitals, clinics, community services and public health work - with the aim of stopping the perverse blocks and incentives that prevent doctors, and other healthcare professionals, from providing the care that patients want and need. Talking to Navjoyt Ladher, are Albert Mulley - professor of medicine at the Dartmouth Institute, and Jane Druce, an evaluations manger, and Donal Collins, a GP - both of whom work in an NHS Vanguard area, where new ways of delivering care are being tested. Read the full analysis: http://www.bmj.com/content/356/bmj.j1401

Listen NowSince the passage of the Affordable Care Act in 2010 CMS has been working to reform Medicare reimbursements from "fee for service" to "fee for value."  (Earlier this year Secretary Burwell noted 30% of traditional or "fee for service" Medicare reimbursements are now tied to quality or value.)  The Medicare Access and CHIP Reauthorization Act (MACRA) passed in 2015 accelerates this transition by incenting Medicare providers to participate in "fee of value" or pay for performance agreements, termed Alternative Payment Models (APMs) under MACRA, with a 5% annual bonus.  To date, commercial Medicare Advantage (MA) plans (Medicare Part D) have been immune from these reforms.   However, under MACRA beginning in performance year 2019 MA plan providers can potentially count their MA reimbursements and MA beneficiaries toward qualifying for the 5% MACRA APM bonus - if they meet the financial risk and other qualifying MACRA APM criteria.  To what extent MA plans, that now account for nearly one-third of all Medicare beneficiaries, will work with their provider partners to meet the MACRA APM qualifying criteria is unknown.      During this 23 minute conversation Ms. Turco discusses expectations for MA plan participation under MACRA as qualifying APMs, how MA stakeholders are thinking about moving the program outside of MACRA toward improved value or reduced spending growth, CMS's MA Value Based Insurance Design (VBID) demonstration scheduled to begin in January and anticipated MA reforms under a new White House administration next year.   Ms. Molly Turco is presently Director of Policy and Research at the Better Medicare.  Previously, Ms. Turco was a Senior Healthcare Policy Analyst with the Marwood Group.   Ms. Turco also worked as a Healthcare Policy Researcher in the State of Vermont Office of Health Reform, within the University of Pennsylvania Health System and at Dartmouth Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth.  Ms. Turco holds a MPH from the Dartmouth Institute for Health Policy and Clinical Practice and a BA from Middlebury College.   This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

Guidelines usually assume a rational comprehensive decision model in which all values, means, and ends are known and considered. In clinical encounters, however, patients and doctors most often follow “the science of muddling through. Given that clinical knowledge does not follow the narrow rationality of “if-then” algorithms contained in guidelines, alternatives are desperately needed. Glyn Elwyn, professor at the Dartmouth Institute for Health Policy and Clinical Practice, joins us to discuss what we know about how doctors and patients use evidence, and what the alternative to guidelines could look like. Read the full analysis: http://www.bmj.com/content/353/bmj.i3200

Dr. Benjamin Berk shares his entrepreneurial journey and passion for improving healthcare systems and patient outcomes. The ModernMD: Dr. Benjamin Berk Dr. Benjamin Berk, MD, MS&E provides strategic and operational consulting services to innovative payers, providers, health services organizations, and investors.  Benjamin is a Senior Advisor and Content Consultant for Advanced Practice Strategies (APS) and Faculty member for The Dartmouth Institute for Health Policy & Clinical Practice. Previously, Dr. Berk was the Vice President of Population Health for Iora Health and Principle at Boston Consulting Group. Success Quote: “Population health is created one patient at a time.” - Benjamin White Coat to Business Suit: Benjamin started as a software engineer building clinical information systems and clinical decision support software.  As he did not want to spend his career behind a computer screen, he decided to go to Stanford Medical school.  During medical school, he realized he was more interested in the ‘big picture' and made the decision to purse his ‘business residency' at BCG. Listen as Dr. Berk shares his journey, reasons for going into consulting, and his start-up adventures. Idea to Venture: The Idea: How can you transform primary care and improve patient outcomes? Listen as Dr. Berk shares his journey at Iora Health and his passion for transforming primary care. Failures: Benjamin shares his thoughts on the value of failure as a learning opportunity that drives innovation. He also shares insights into fear of failure and success motivators in the US vs. UK healthcare marketplace. Lessons Learned: The buy vs. build technology decision - Learn when buy software and when to build and promote rapid innovation.  Business Rounds: Best Advice: “Opportunity is everywhere.” -  Benjamin's parents Daily Success Habit: Takes personal time daily to relax away from work without distractions.  Healthcare Trends: Value Based Healthcare: Healthcare is moving to larger systems with value based care and accountable care. Healthcare Technology: Clinical dashboards are being brought to the point of care with actionable data. Links: http://tdi.dartmouth.edu/ http://www.aps-web.com/